 |
|
The mutational landscape of hepatocellular carcinoma
Ju-Seog Lee
Clin Mol Hepatol. 2015;21(3):220-229. Published online 2015 Sep 30 DOI: https://doi.org/10.3350/cmh.2015.21.3.220
|
|
Citations to this article as recorded by
 Identification and validation of methylation-CpG prognostic signature for prognosis of hepatocellular carcinoma
Chunmei He, Zehao Guo, Hao Zhang, Ganqing Yang, Jintao Gao, Zhijing Mo
Aging.2024; 16(2): 1733. CrossRef Pre-enrichment-free detection of hepatocellular carcinoma-specific ctDNA via PDMS and MEMS-based microfluidic sensor
Zeynep Çağlayan Arslan, Meltem Okan, Haluk Külah
Microchimica Acta.2024;[Epub] CrossRef
FOXA1
/2 depletion drives global reprogramming of differentiation state and metabolism in a human liver cell line and inhibits differentiation of human stem cell‐derived hepatic progenitor cells
Iyan Warren, Michael M. Moeller, Daniel Guiggey, Alexander Chiang, Mitchell Maloy, Ogechi Ogoke, Theodore Groth, Tala Mon, Saber Meamardoost, Xiaojun Liu, Sarah Thompson, Antoni Szeglowski, Ryan Thompson, Peter Chen, Ramasamy Paulmurugan, Martin L. Yarmus
The FASEB Journal.2023;[Epub] CrossRef PRIMA-1 inhibits Y220C p53 amyloid aggregation and synergizes with cisplatin in hepatocellular carcinoma
Mariana M. Paz, Giulia D. S. Ferretti, Mafalda M. C. Martins-Dinis, Beatriz I. S. Ferreira, Amanda Faier-Pereira, Thibaut Barnoud, Otacilio C. Moreira, Jerson L. Silva, Yraima Cordeiro, Luciana P. Rangel
Frontiers in Molecular Biosciences.2023;[Epub] CrossRef A comprehensive study on signal transduction and therapeutic role of miR-877 in human cancers
Milad Rafat, Mahdis Kohsarian, Mohamad Bahiraei, AminR Nikpoor
Advanced Biomedical Research.2023; 12(1): 118. CrossRef The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review
Agnieszka Kopystecka, Rafał Patryn, Magdalena Leśniewska, Julia Budzyńska, Ilona Kozioł
International Journal of Molecular Sciences.2023; 24(11): 9342. CrossRef Spotlight on the expanding role of miR-647 in human cancers
Mohammadmahdi Jalili, Setayesh Tavakoli, Kamran Kargar, Milad Rafat, FatemehR Rad
Advanced Biomedical Research.2023; 12(1): 170. CrossRef
Hepatocellular Carcinomas with Concomitant Mutations of TERT, TP53, and CTNNB1: Is There a Role for Artificial Intelligence?
Stefano Chillotti, Thais Maloberti, Alessio Degiovanni, Deborah Malvi, Antonia D'Errico, Dario de Biase, Francesco Vasuri
Critical Reviews™ in Oncogenesis.2023; 28(3): 31. CrossRef Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers
Guoying Zhou, Patrick P. C. Boor, Marco J. Bruno, Dave Sprengers, Jaap Kwekkeboom
British Journal of Cancer.2022; 126(1): 10. CrossRef TIA1 Loss Exacerbates Fatty Liver Disease but Exerts a Dual Role in Hepatocarcinogenesis
Dobrochna Dolicka, Szabolcs Zahoran, Marta Correia de Sousa, Monika Gjorgjieva, Christine Sempoux, Margot Fournier, Christine Maeder, Martine A. Collart, Michelangelo Foti, Cyril Sobolewski
Cancers.2022; 14(7): 1704. CrossRef Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18–21 mutations
Dafina Nikolova, Meri Trajkovska, Emilija Nikolovska Trpcevska, Aleksandar Eftimov, Rubens Jovanovik, Vesna Janevska
Romanian Journal of Internal Medicine.2022; 60(3): 153. CrossRef Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers
Zachary L Skidmore, Jason Kunisaki, Yiing Lin, Kelsy C Cotto, Erica K Barnell, Jasreet Hundal, Kilannin Krysiak, Vincent Magrini, Lee Trani, Jason R Walker, Robert Fulton, Elizabeth M Brunt, Christopher A Miller, Richard K Wilson, Elaine R Mardis, Malachi
Cancer Genetics.2022; 264-265: 90. CrossRef Suppressors of Cytokine Signaling and Hepatocellular Carcinoma
Ryota Masuzaki, Tatsuo Kanda, Reina Sasaki, Naoki Matsumoto, Kazushige Nirei, Masahiro Ogawa, Seth J. Karp, Mitsuhiko Moriyama, Hirofumi Kogure
Cancers.2022; 14(10): 2549. CrossRef Tumor Promoting Effects of Sulforaphane on Diethylnitrosamine-Induced Murine Hepatocarcinogenesis
Jie Zheng, Do-Hee Kim, Xizhu Fang, Seong Hoon Kim, Soma Saeidi, Su-Jung Kim, Young-Joon Surh
International Journal of Molecular Sciences.2022; 23(10): 5397. CrossRef Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes
Sung Hwan Lee, Sun Young Yim, Yun Seong Jeong, Qi‐Xiang Li, Sang‐Hee Kang, Bo Hwa Sohn, Shwetha V. Kumar, Ji‐Hyun Shin, You Rhee Choi, Jae‐Jun Shim, Hayeon Kim, Ji Hoon Kim, Shin Kim, Sheng Guo, Randy L. Johnson, Ahmed Kaseb, Koo Jeong Kang, Yun Shin Chun
Hepatology.2022; 76(6): 1634. CrossRef The prominent role of miR-942 in carcinogenesis of tumors
Negar Yadegar, Zahra Dadashi, Kimiya Shams, Mahdis Mohammadi, Mahya Abyar, Milad Rafat
Advanced Biomedical Research.2022; 11(1): 63. CrossRef Multi-Omics and Artificial Intelligence-Guided Data Integration in Chronic Liver Disease: Prospects and Challenges for Precision Medicine
Biaoyang Lin, Yingying Ma, ShengJun Wu
OMICS: A Journal of Integrative Biology.2022; 26(8): 415. CrossRef Mutational signatures representative transcriptomic perturbations in hepatocellular carcinoma
Qiong Wu, Lingyi Wang, Stephen Kwok-Wing Tsui
Frontiers in Genetics.2022;[Epub] CrossRef Hepatocellular Carcinoma: Current Therapeutic Algorithm for Localized and Advanced Disease
Anju Jose, Maria Grazia Bavetta, Erika Martinelli, Fabrizio Bronte, Emilio Francesco Giunta, Kanjoormana Aryan Manu, Alessandro Granito
Journal of Oncology.2022; 2022: 1. CrossRef Exploring the Interplay of Telomerase Reverse Transcriptase and β-Catenin in Hepatocellular Carcinoma
Srishti Kotiyal, Kimberley Jane Evason
Cancers.2021; 13(16): 4202. CrossRef Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy
Xiao-Yan Jiang, Bing Huang, Dan-Ping Huang, Chun-Shan Wei, Wei-Chao Zhong, De-Ti Peng, Fu-Rong Huang, Guang-Dong Tong
World Journal of Gastroenterology.2021; 27(11): 1101. CrossRef Detection of CTNNB1 Hotspot Mutations in Cell-Free DNA from the Urine of Hepatocellular Carcinoma Patients
Selena Y. Lin, Ting-Tsung Chang, Jamin D. Steffen, Sitong Chen, Surbhi Jain, Wei Song, Yih-Jyh Lin, Ying-Hsiu Su
Diagnostics.2021; 11(8): 1475. CrossRef Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma
Jeong-Won Jang, Jin-Seoub Kim, Hye-Seon Kim, Kwon-Yong Tak, Soon-Kyu Lee, Hee-Chul Nam, Pil-Soo Sung, Chang-Min Kim, Jin-Young Park, Si-Hyun Bae, Jong-Young Choi, Seung-Kew Yoon
Cancers.2021; 13(9): 2160. CrossRef Kill and Clearance in HCC: An Approach Based on NK Cells and Macrophages
Maryam Mehrabi, Fatemeh Amini, Shima Mehrabi
Frontiers in Oncology.2021;[Epub] CrossRef Hepatic IFNL4 Gene Activation in Hepatocellular Carcinoma Patients with Regard to Etiology
Henriette Huschka, Sabine Mihm
International Journal of Molecular Sciences.2021; 22(15): 7803. CrossRef Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer
Kyung Joo Cho, Sun Yeong Shin, Hyuk Moon, Beom Kyung Kim, Simon Weonsang Ro
Translational Oncology.2021; 14(9): 101158. CrossRef Integrative Pan-Cancer Analysis Reveals Decreased Melatonergic Gene Expression in Carcinogenesis and RORA as a Prognostic Marker for Hepatocellular Carcinoma
Yi Zou, Huaqin Sun, Yating Guo, Yidan Shi, Zhiyu Jiang, Jingxuan Huang, Li Li, Fengle Jiang, Zeman Lin, Junling Wu, Ruixiang Zhou, Yuncai Liu, Lu Ao
Frontiers in Oncology.2021;[Epub] CrossRef Primary hepatic neoplasms arising in cirrhotic livers can have a variable spectrum of neuroendocrine differentiation
Chanjuan Shi, Rachel Jug, Sarah M. Bean, William R. Jeck, Cynthia D. Guy
Human Pathology.2021; 116: 63. CrossRef An Overview of the Genomic Characterization of Hepatocellular Carcinoma
Sun Young Yim, Ju-Seog Lee
Journal of Hepatocellular Carcinoma.2021; Volume 8: 1077. CrossRef Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma
Stine Karlsen Oversoe, Michelle Simone Clement, Britta Weber, Henning Grønbæk, Stephen Jacques Hamilton-Dutoit, Boe Sandahl Sorensen, Jens Kelsen
BMC Cancer.2021;[Epub] CrossRef Exploring the Mechanisms of Arsenic Trioxide (Pishuang) in Hepatocellular Carcinoma Based on Network Pharmacology
Xinmiao Wang, Luchang Cao, Jingyuan Wu, Guanghui Zhu, Xiaoyu Zhu, Xiaoxiao Zhang, Duoduo Han, Ning Shui, Baoyi Ni, Jie Li, Jie Liu
Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1. CrossRef Associations of Serum Tumor Biomarkers with Integrated Genomic and Clinical Characteristics of Hepatocellular Carcinoma
Keun Soo Ahn, Daniel R. O’Brien, Yong Hoon Kim, Tae-Seok Kim, Hiroyuki Yamada, Joong-Won Park, Sang-Jae Park, Seoung Hoon Kim, Cheng Zhang, Hu Li, Koo Jeong Kang, Lewis R. Roberts
Liver Cancer.2021; 10(6): 593. CrossRef Regulation of expression of drug-metabolizing enzymes by oncogenic signaling pathways in liver tumors: a review
Albert Braeuning, Michael Schwarz
Acta Pharmaceutica Sinica B.2020; 10(1): 113. CrossRef Tumor‐Specific Transcripts Are Frequently Expressed in Hepatocellular Carcinoma With Clinical Implication and Potential Function
Qiupeng Zheng, Jingjing Zhao, Hui Yu, Huajie Zong, Xigan He, Yiming Zhao, Yan Li, Yu Wang, Yichao Bao, Yuchen Li, Bing Chen, Weijie Guo, Yilin Wang, Zhiao Chen, Yingjun Zhao, Lu Wang, Xianghuo He, Shenglin Huang
Hepatology.2020; 71(1): 259. CrossRef Tumor-Stroma Crosstalk Enhances REG3A Expressions that Drive the Progression of Hepatocellular Carcinoma
Yuri Cho, Min Ji Park, Koeun Kim, Jae-Young Park, Jihye Kim, Wonjin Kim, Jung-Hwan Yoon
International Journal of Molecular Sciences.2020; 21(2): 472. CrossRef Engineering T cells for immunotherapy of primary human hepatocellular carcinoma
Leidy D. Caraballo Galva, Lun Cai, Yanxia Shao, Yukai He
Journal of Genetics and Genomics.2020; 47(1): 1. CrossRef Analysis of TP53 aflatoxin signature mutation in hepatocellular carcinomas from Guatemala: A cross‐sectional study (2016‐2017)
Christian S. Alvarez, Jeremy Ortiz, Giovanna Bendfeldt‐Avila, Yi Xie, Mingyi Wang, Dongjing Wu, Herbert Higson, Elisa Lee, Kedest Teshome, Joaquin Barnoya, David E. Kleiner, John D. Groopman, Roberto Orozco, Katherine A. McGlynn, Eduardo Gharzouzi, Michae
Health Science Reports.2020;[Epub] CrossRef New Advances in Canonical Wnt/β-Catenin Signaling in Cancer Xiaolan Wen, Yanling Wu, Annoor Awadasseid, Yoshimasa Tanaka, Wen Zhang
Cancer Management and Research.2020; Volume 12: 6987. CrossRef Metallophosphoesterase 1, a novel candidate gene in hepatocellular carcinoma malignancy and recurrence
Xinguo Chen, Jing Xu, Peixiao Wang, Lei Shang, Jing Guo, Lihong Huang, Yide A. Jiang, Jinhong Chen, Huijuan Chen, Yukui Shang, Qing Zhang
Cancer Biology & Therapy.2020; 21(11): 1005. CrossRef Computational analysis of TP53 vs. CTNNB1 mutations in hepatocellular carcinoma suggests distinct cancer subtypes with differential gene expression profiles and chromatin states
Burcu Biterge Süt
Computational Biology and Chemistry.2020; 89: 107404. CrossRef Reactive oxygen species-induced activation of Yes-associated protein-1 through the c-Myc pathway is a therapeutic target in hepatocellular carcinoma
Yuri Cho, Min Ji Park, Koeun Kim, Sun Woong Kim, Wonjin Kim, Sooyeon Oh, Joo Ho Lee
World Journal of Gastroenterology.2020; 26(42): 6599. CrossRef PIDDosome‐induced p53‐dependent ploidy restriction facilitates hepatocarcinogenesis
Valentina C Sladky, Katja Knapp, Tamas G Szabo, Vincent Z Braun, Laura Bongiovanni, Hilda van den Bos, Diana CJ Spierings, Bart Westendorp, Ana Curinha, Tatjana Stojakovic, Hubert Scharnagl, Gerald Timelthaler, Kaoru Tsuchia, Matthias Pinter, Georg Semmle
EMBO reports.2020;[Epub] CrossRef Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma
Roseane Guimarães Ferreira, Magda Vieira Cardoso, Karine Maria de Souza Furtado, Kaio Murilo Monteiro Espíndola, Ruanderson Pereira Amorim, Marta Chagas Monteiro
Translational Research.2019; 204: 51. CrossRef Systemic treatment of advanced hepatocellular cancer: new hope on the horizon
Rachael Chang Lee, Niall Tebbutt
Expert Review of Anticancer Therapy.2019; 19(4): 343. CrossRef Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies
Saad Saffo, Tamar H. Taddei
Digestive Diseases and Sciences.2019; 64(4): 1016. CrossRef Transcriptome Analysis Revealed a Highly Connected Gene Module Associated With Cirrhosis to Hepatocellular Carcinoma Development
Shan Shan, Wei Chen, Ji-dong Jia
Frontiers in Genetics.2019;[Epub] CrossRef MiR-942-3p Promotes the Proliferation and Invasion of Hepatocellular Carcinoma Cells by Targeting MBL2
Chun-Yang Xu, Jun-Feng Dong, Zi-Qi Chen, Guo-Shan Ding, Zhi-Ren Fu
Cancer Control.2019; 26(1): 107327481984659. CrossRef SET domain containing 1B gene is mutated in primary hepatic neuroendocrine tumors
Penghui Yang, Xuanlin Huang, Chengcai Lai, Lin Li, Tieling Li, Peide Huang, Songying Ouyang, Jin Yan, Sijie Cheng, Guanglin Lei, Zhaohai Wang, Linxiang Yu, Zhixian Hong, Ruisheng Li, Hui Dong, Cheng Wang, Yinghao Yu, Xuan Wang, Xianghong Li, Liming Wang,
International Journal of Cancer.2019; 145(11): 2986. CrossRef Hepatocyte growth control by SOCS1 and SOCS3
Md Gulam Musawwir Khan, Amit Ghosh, Bhavesh Variya, Madanraj Appiya Santharam, Rajani Kandhi, Sheela Ramanathan, Subburaj Ilangumaran
Cytokine.2019; 121: 154733. CrossRef Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis
Marc Bonnin, Nadim Fares, Barbara Testoni, Yann Estornes, Kathrin Weber, Béatrice Vanbervliet, Lydie Lefrançois, Amandine Garcia, Alain Kfoury, Floriane Pez, Isabelle Coste, Pierre Saintigny, Alain Viari, Kévin Lang, Baptiste Guey, Valérie Hervieu, Brigit
Journal of Hepatology.2019; 71(4): 763. CrossRef There Is Something Fishy About Liver Cancer: Zebrafish Models of Hepatocellular Carcinoma
Paul J. Wrighton, Isaac M. Oderberg, Wolfram Goessling
Cellular and Molecular Gastroenterology and Hepatology.2019; 8(3): 347. CrossRef Knockdown expression of MECR, a novel gene of mitochondrial FAS II inhibits growth and colony-formation, promotes apoptosis of hepatocelluar carcinoma cells
Yulong Cai, Yixin Lin, Xianze Xiong, Jiong Lu, Rongxing Zhou, Yanwen Jin, Zhen You, Hui Ye, Fuyu Li, Nansheng Cheng
BioScience Trends.2019; 13(3): 234. CrossRef Immune suppression in chronic hepatitis B infection associated liver disease: A review
Tian-Yang Li, Yang Yang, Guo Zhou, Zheng-Kun Tu
World Journal of Gastroenterology.2019; 25(27): 3527. CrossRef Genomic Perspective on Mouse Liver Cancer Models
Sun Young Yim, Ju-Seog Lee
Cancers.2019; 11(11): 1648. CrossRef RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma
Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, Maria R. Emma, Giuseppa Augello, Antonella Cusimano, Antonina Azzolina, Giuseppe Montalto, Melchiorre Cervello, James A. McCubrey
Expert Opinion on Therapeutic Targets.2019; 23(11): 915. CrossRef Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma
Lokau, Schoeder, Haybaeck, Garbers
Cancers.2019; 11(11): 1704. CrossRef Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype
Sang Cheul Oh, Bo Hwa Sohn, Jae-Ho Cheong, Sang-Bae Kim, Jae Eun Lee, Ki Cheong Park, Sang Ho Lee, Jong-Lyul Park, Yun-Yong Park, Hyun-Sung Lee, Hee-Jin Jang, Eun Sung Park, Sang-Cheol Kim, Jeonghoon Heo, In-Sun Chu, You-Jin Jang, Young-Jae Mok, WonKyung
Nature Communications.2018;[Epub] CrossRef Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma
Thomas T DeLeon, Daniel H Ahn, James M Bogenberger, Panos Z Anastasiadis, Mansi Arora, Ramesh K Ramanathan, Bashar A Aqel, George Vasmatzis, Mark J Truty, Rahmi Oklu, Tanios S Bekaii-Saab, Mitesh J Borad
Future Oncology.2018; 14(6): 553. CrossRef Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma
Ping An, Jinghang Xu, Yanyan Yu, Cheryl A. Winkler
Frontiers in Genetics.2018;[Epub] CrossRef Clinical significance of APOB inactivation in hepatocellular carcinoma
Gena Lee, Yun Seong Jeong, Do Won Kim, Min Jun Kwak, Jiwon Koh, Eun Wook Joo, Ju-Seog Lee, Susie Kah, Yeong-Eun Sim, Sun Young Yim
Experimental & Molecular Medicine.2018; 50(11): 1. CrossRef Association between long non-coding RNAs expression and pathogenesis and progression of gliomas (Review)
Jie Zhou, Wei Xiang, Shenjie Li, Qi Hu, Tao Peng, Ligang Chen, Yang Ming
Oncology Letters.2018;[Epub] CrossRef Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma
Supritha G. Swamy, Vivek H. Kameshwar, Priya B. Shubha, Chung Yeng Looi, Muthu K. Shanmugam, Frank Arfuso, Arunasalam Dharmarajan, Gautam Sethi, Nanjunda Swamy Shivananju, Anupam Bishayee
Targeted Oncology.2017; 12(1): 1. CrossRef Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment
Hyo Jung Cho, Soon Sun Kim, Ji Sun Nam, Jai Keun Kim, Jei Hee Lee, Bohyun Kim, Hee Jung Wang, Bong Wan Kim, Jung-Dong Lee, Dae Yong Kang, Ji Hyun Kim, Yang Min Jae, Jae Chul Hwang, Sung Jae Shin, Kee Myung Lee, Sung Won Cho, Jae Youn Cheong
Clinics and Research in Hepatology and Gastroenterology.2017; 41(2): 181. CrossRef Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular Carcinoma
Nadia Panera, Annalisa Crudele, Ilaria Romito, Daniela Gnani, Anna Alisi
International Journal of Molecular Sciences.2017; 18(1): 99. CrossRef Soy protein isolate inhibits hepatic tumor promotion in mice fed a high-fat liquid diet
Kelly E Mercer, Casey F Pulliam, Kim B. Pedersen, Leah Hennings, Martin JJ Ronis
Experimental Biology and Medicine.2017; 242(6): 635. CrossRef Gene expression profiling of circulating CD133 + cells of hepatocellular carcinoma patients associated with HCV infection
Abdel-Rahman N. Zekri, Enas R. El-Sisi, Zeinab F. Abdallah, Alaa Ismail, Ahmed Barakat Barakat
Journal of the Egyptian National Cancer Institute.2017; 29(1): 19. CrossRef Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma
Young‐Joo Kim, Hyungjin Rhee, Jeong Eun Yoo, Venancio A F Alves, Gi Jeong Kim, Hye Min Kim, Paulo Herman, Aline Chagas, Haeryoung Kim, Young Nyun Park
Histopathology.2017; 71(2): 217. CrossRef Precision medicine for hepatocelluar carcinoma using molecular pattern diagnostics: results from a preclinical pilot study
Rahul Agarwal, Yuan Cao, Klaus Hoffmeier, Nicolas Krezdorn, Lukas Jost, Alejandro Rodriguez Meisel, Ruth Jüngling, Francesco Dituri, Serena Mancarella, Björn Rotter, Peter Winter, Gianluigi Giannelli
Cell Death & Disease.2017; 8(6): e2867. CrossRef Chronic viral hepatitis and its association with liver cancer
Thomas Tu, Sandra Bühler, Ralf Bartenschlager
Biological Chemistry.2017; 398(8): 817. CrossRef BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness
Benedikt Kaufmann, Baocai Wang, Suyang Zhong, Melanie Laschinger, Pranali Patil, Miao Lu, Volker Assfalg, Zhangjun Cheng, Helmut Friess, Norbert Hüser, Guido von Figura, Daniel Hartmann, Aamir Ahmad
PLOS ONE.2017; 12(7): e0180225. CrossRef WITHDRAWN: Epigenetics in Chronic Liver Disease
Marie Boyle, Jelena Mann
Journal of Hepatology.2017;[Epub] CrossRef Stress Hormone Cortisol Enhances Bcl2 Like-12 Expression to Inhibit p53 in Hepatocellular Carcinoma Cells
Weizhong Wu, Sanguang Liu, Yunfei Liang, Zegao Zhou, Wei Bian, Xueqing Liu
Digestive Diseases and Sciences.2017; 62(12): 3495. CrossRef Evolving role of Sorafenib in the management of hepatocellular carcinoma
Ioannis A Ziogas, Georgios Tsoulfas
World Journal of Clinical Oncology.2017; 8(3): 203. CrossRef Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
Xiao-Xiao Ding, Qing-Ge Zhu, Shi-Ming Zhang, Lei Guan, Ting Li, Lei Zhang, Shi-Yang Wang, Wan-Li Ren, Xue-Mei Chen, Jing Zhao, Song Lin, Zhi-Zhen Liu, Yan-Xia Bai, Bing He, Hu-Qin Zhang
Oncotarget.2017; 8(33): 55715. CrossRef Hypoxia Enhances Tumor-Stroma Crosstalk that Drives the Progression of Hepatocellular Carcinoma
Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Chung Yong Kim, Jung-Hwan Yoon
Digestive Diseases and Sciences.2016; 61(9): 2568. CrossRef 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling
Seulki Lee, Minjong Lee, Jong Bin Kim, Ara Jo, Eun Ju Cho, Su Jong Yu, Jeong-Hoon Lee, Jung-Hwan Yoon, Yoon Jun Kim
Biochemical and Biophysical Research Communications.2016; 473(4): 1247. CrossRef Interplay of genetic and epigenetic alterations in hepatocellular carcinoma
Sun-Min Lee, Jeongsil Kim-Ha, Won-Young Choi, Jungwoo Lee, Dawon Kim, Jinyoung Lee, Eunji Choi, Young-Joon Kim
Epigenomics.2016; 8(7): 993. CrossRef Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells
Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Chung Yong Kim, Jung-Hwan Yoon
Biomedicine & Pharmacotherapy.2016; 83: 607. CrossRef Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14
Yuri Cho, Yun Bin Lee, Jeong-Hoon Lee, Dong Hyeon Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jong In Kim, Jong Hun Im, Jung Hwan Lee, Eun Ju Oh, Jung-Hwan Yoon, Seung Up Kim
PLOS ONE.2016; 11(8): e0160822. CrossRef
|